Actively Recruiting

All Genders
Healthy Volunteers
NCT05982691

Development of Asian Consortium for Data Collection and Clinical Trial of CNS Tumors

Led by National Cancer Center, Korea · Updated on 2023-08-08

400

Participants Needed

1

Research Sites

543 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

\<Purpose of the Research\> * Primary Establishing an Asian consortium to establish a database of pediatric CNS tumors in the prospective manner The target disease of this research focuses on pediatric tumors, and initially the registration of patients with CNS GCT will begin first. * Secondary Developing clinical protocols for pediatric CNS tumors based in Asia \<Duration of Research Participation\> Registration period for research subjects: 2022-08-01 - 2027-12-31 Duration of medical records to be utilized: to 2030-12-31 Total projected duration of research: IRB approved to 2032-12-31 Interim assessment of data quality and integrity: 6 Mo after Data collection Evaluation for the Adaptation of Protocols: 1 and 2 years after the initiation of the study Analysis of Quality of Life and other questionnaires: 3 and 5 years Interim Analysis of all data: 5 years (2027) Final analysis of treatment outcome: 2032

CONDITIONS

Official Title

Development of Asian Consortium for Data Collection and Clinical Trial of CNS Tumors

Who Can Participate

All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of CNS germ cell tumor (CNS GCT) and agreement to participate between 2022 and 2027
  • Patients diagnosed between 2016 and 2022 may be enrolled if the institute has IRB approval or consent for research
  • Age at diagnosis between greater than 0 and 40 years
  • Diagnosis confirmed by operation or biopsy; for CNS germinoma, biopsy may be absent if radiology strongly suggests germinoma and tumor markers are consistent
Not Eligible

You will not qualify if you...

  • Patient or guardian did not consent to participate

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

National Cancer Center, Korea

Goyang-si, Gyeonggi-do, South Korea, 410-769

Actively Recruiting

Loading map...

Research Team

J

Joo-young Kim, M.D., Ph.D.

CONTACT

S

songei Yang, MPH

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here